Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

MetLife to meet skeptical regulators in bid to escape rules

Published 11/03/2014, 01:08 AM
Updated 11/03/2014, 01:10 AM
© Reuters The MetLife building is seen in New York

By Douwe Miedema WASHINGTON (Reuters) - MetLife, the largest U.S. insurer, will make a final plea on Monday to a group of U.S. regulators determined to subject it to tougher oversight as they probe which firms could pose a risk to the larger financial system.

MetLife will meet behind closed doors the heads of the agencies grouped together in the Financial Stability Oversight Council (FSOC), who want the Federal Reserve to oversee MetLife's business and force it to meet higher capital standards.

Metlife, unlike counterparts AIG and Prudential which have already been deemed "systemic" by FSOC, has vigorously fought the tag.

After FSOC in September proposed to add MetLife to that group, the insurer's chief executive Steven Kandarian hit back. He issued a statement saying MetLife was a source of strength during the 2008 financial crisis and that the insurer was "not ruling out any of the available remedies."

But observers say MetLife faces an uphill battle, especially after an international body of regulators had already deemed MetLife systemic on a global level in July 2013.

"MetLife has a strong case on the substance ... but the FSOC is not likely to listen," said Phillip Swagel, a professor at the University of Maryland School of Public Policy who was a senior Treasury official during the recent credit crisis.

FSOC is housed within the Treasury Department, which also chairs the group, and is comprised of the leaders of all the major U.S. financial regulators.

After hearing from MetLife on Monday, the first such in-person meeting between the insurer and the top regulators after months of staff-level talks, regulators will have 60 days for a final decision. MetLife can challenge the decision in court.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Metlife declined to comment.

SHADOW INSURANCE

The 2010 Dodd-Frank Wall Street reform act automatically designated banks with more than $50 billion in assets as "systemically important financial institutions."

But it gave the risk council the power to also tap financial firms that are not banks, if they are so big and risky that their activities could destabilize U.S. markets.

To date, the regulators who make up FSOC have not spoken publicly about MetLife. However, public documents justifying their designations of AIG and Prudential, and FSOC's annual report, shed light on their concerns.

The watchdogs worry insurers have their fingers in too many risky activities even after the credit crisis, and that they are no longer just straightforward providers of traditional life or car insurance policies.

One issue likely to be weighed is captive reinsurance, an accounting practice through which life insurers can lower their reserves, or funds set aside to pay claims.

In captive reinsurance, life insurance companies transfer risk to entities affiliated with their business in overseas jurisdictions or U.S. states with light-touch rules, which allows them to free up regulatory capital.

Benjamin Lawsky, the New York Superintendent for Financial Services, has stopped issuing licenses for such activity, which he called "shadow insurance," while Vermont and Delaware still actively court the business.

In an apparent effort to reduce some scrutiny, MetLife last year announced it would merge three of its life insurance companies and a Bermuda-based captive reinsurance unit into one U.S.-based company, to "address regulatory concerns about the use of captive reinsurance."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Another point regulators have looked into is securities lending. Insurers hold huge portfolios of stocks and bonds that they often lend out, typically to broker-dealers or hedge funds, backed by collateral, in return for a small fee.

This is generally seen as a low-risk activity, but played a key role in the near-collapse of AIG, which was reinvesting much of its collateral in often complex and risky instruments that rapidly lost their value when the crisis hit.

Insurers say such risky behavior is a thing of the past, yet they continue to lend out considerable amounts of securities. MetLife's securities lending portfolio ended 2013 at $28 billion, according to Moody's Investors Service.

Lastly, regulators are wary about a possible run on an insurer much in the same way as on a bank. The industry is fiercely contesting this perception, saying their business model is different, and funding more stable.

But the Federal Insurance Office, a Treasury unit that monitors the industry, last year pointed out that AIG was not the only U.S. insurer in trouble. Insurers Hartford Financial Services Group and Lincoln National Corp both received taxpayer aid during the crisis.

(Reporting by Douwe Miedema; Editing by Karey Van Hall and Richard Chang)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.